[Federal Register Volume 80, Number 159 (Tuesday, August 18, 2015)]
[Notices]
[Pages 50049-50050]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2015-20364]


=======================================================================
-----------------------------------------------------------------------

NUCLEAR REGULATORY COMMISSION


Advisory Committee on the Medical Uses of Isotopes: Meeting 
Notice

AGENCY: U.S. Nuclear Regulatory Commission.

ACTION: Notice of meeting.

-----------------------------------------------------------------------

SUMMARY: NRC will convene a meeting of the Advisory Committee on the 
Medical Uses of Isotopes (ACMUI) on October 8-9, 2015. A sample of 
agenda items to be discussed during the public session includes: (1) A 
discussion on training and experience for alpha and beta emitters; (2) 
a discussion on Title 10 of the Code of Federal Regulations (10 CFR) 
section 35.1000 licensing guidance for the use of iodine-125 and 
palladium-103 seeds for localization of non-palpable lesions; (3) a 
presentation on the proposed revisions to the 10 CFR 35.1000 licensing 
guidance for Yttrium-90 microspheres brachytherapy; (4) a status update 
on the decommissioning funding plan requirements for

[[Page 50050]]

germanium-68/gallium-68 generators; (5) a discussion on the project and 
upcoming workshops related to patients who are administered 
radionuclides; (6) a discussion on NUREG 1556, Volume 9, ``Consolidated 
Guidance About Materials Licenses: Program-Specific Guidance About 
Medical Use Licensees;'' (7) an update on the current 10 CFR part 35 
rulemaking effort; and (8) a presentation on the proposed revisions to 
the NRC's Abnormal Occurrence Reporting Criteria Policy Statement. The 
agenda is subject to change. The current agenda and any updates will be 
available at http://www.nrc.gov/reading-rm/doc-collections/acmui/meetings/2015.html or by emailing Ms. Sophie Holiday at the contact 
information below.
    Purpose: Discuss issues related to 10 CFR part 35 ``Medical Use of 
Byproduct Material.''
    Date and Time for Closed Sessions: October 8, 2015, from 7:30 a.m. 
to 8:30 a.m. and October 8, 2015, from 3:30 p.m. to 5:30 p.m. Both 
sessions on October 8, 2015, will be closed for badging and enrollment 
for new members to the ACMUI and annual required training.
    Date and Time for Open Sessions: October 8, 2015, from 8:30 a.m. to 
3:30 p.m. and October 9, 2015, from 8:00 a.m. to 4:00 p.m.
    Address for Public Meeting: U.S. Nuclear Regulatory Commission, Two 
White Flint North Building, Room T2-B3, 11545 Rockville Pike, 
Rockville, Maryland 20852.
    Public Participation: Any member of the public who wishes to 
participate in the meeting in person or via phone should contact Ms. 
Holiday using the information below. The meeting will also be webcast 
live: video.nrc.gov.

FOR FURTHER INFORMATION CONTACT: Ms. Sophie J. Holiday, email: 
[email protected], telephone: (404) 997-4691.

Conduct of the Meeting

    Bruce R. Thomadsen, Ph.D., will chair the meeting. Dr. Thomadsen 
will conduct the meeting in a manner that will facilitate the orderly 
conduct of business. The following procedures apply to public 
participation in the meeting:
    1. Persons who wish to provide a written statement should submit an 
electronic copy to Ms. Holiday at the contact information listed above. 
All submittals must be received by October 5, 2015, and must pertain to 
the topic on the agenda for the meeting.
    2. Questions and comments from members of the public will be 
permitted during the meeting, at the discretion of the Chairman.
    3. The draft transcript and meeting summary will be available on 
ACMUI's Web site http://www.nrc.gov/reading-rm/doc-collections/acmui/meetings/2015.html on or about November 24, 2015.
    4. Persons who require special services, such as those for the 
hearing impaired, should notify Ms. Holiday of their planned 
attendance.
    This meeting will be held in accordance with the Atomic Energy Act 
of 1954, as amended (primarily Section 161a); the Federal Advisory 
Committee Act (5 U.S.C. App); and the Commission's regulations in 10 
CFR part 7.

    Dated at Rockville, Maryland, this 12th day of August, 2015.
    For the Nuclear Regulatory Commission.
Andrew L. Bates,
Advisory Committee Management Officer.
[FR Doc. 2015-20364 Filed 8-17-15; 8:45 am]
BILLING CODE 7590-01-P